These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19566775)

  • 1. Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence.
    Okahisa Y; Ujike H; Kotaka T; Morita Y; Kodama M; Inada T; Yamada M; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):417-22. PubMed ID: 19566775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.
    Ide S; Kobayashi H; Ujike H; Ozaki N; Sekine Y; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Iwata N; Tanaka K; Shen H; Iwahashi K; Itokawa M; Minami M; Satoh M; Ikeda K; Sora I
    Pharmacogenomics J; 2006; 6(3):179-88. PubMed ID: 16402083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.
    Ujike H; Sakai A; Nakata K; Tanaka Y; Kodaka T; Okahisa Y; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():90-6. PubMed ID: 17105906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence.
    Morio A; Ujike H; Nomura A; Tanaka Y; Morita Y; Otani K; Kishimoto M; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():411-7. PubMed ID: 17105939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence.
    Nomura A; Ujike H; Tanaka Y; Kishimoto M; Otani K; Morita Y; Morio A; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():116-24. PubMed ID: 17105909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
    Aoyama N; Takahashi N; Kitaichi K; Ishihara R; Saito S; Maeno N; Ji X; Takagi K; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Iwata N; Inada T; Ozaki N
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1644-9. PubMed ID: 17010131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of single nucleotide polymorphisms and haplotypes in the neuropeptide Y gene: no evidence for association with alcoholism in a German population sample.
    Zill P; Preuss UW; Koller G; Bondy B; Soyka M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):430-4. PubMed ID: 18241322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.
    Kobayashi H; Ide S; Hasegawa J; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Shen HW; Ikeda K; Sora I
    Ann N Y Acad Sci; 2004 Oct; 1025():325-34. PubMed ID: 15542733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
    Morita Y; Ujike H; Tanaka Y; Uchida N; Nomura A; Ohtani K; Kishimoto M; Morio A; Imamura T; Sakai A; Inada T; Harano M; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2005 Mar; 376(3):182-7. PubMed ID: 15721218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia.
    Inoue Y; Shinkai T; Utsunomiya K; Sakata S; Fukunaka Y; Yamaguchi W; Yamada K; Chen HI; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2009 Mar; 452(1):72-4. PubMed ID: 19150389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G72 gene is associated with susceptibility to methamphetamine psychosis.
    Kotaka T; Ujike H; Okahisa Y; Takaki M; Nakata K; Kodama M; Inada T; Yamada M; Uchimura N; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1046-9. PubMed ID: 19482054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene polymorphisms of the mu opioid receptor in methamphetamine abusers.
    Ide S; Kobayashi H; Tanaka K; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Ikeda K; Sora I
    Ann N Y Acad Sci; 2004 Oct; 1025():316-24. PubMed ID: 15542732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.
    Otani K; Ujike H; Sakai A; Okahisa Y; Kotaka T; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2008 Mar; 434(1):88-92. PubMed ID: 18280655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
    Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
    Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence.
    Nomura A; Ujike H; Tanaka Y; Otani K; Morita Y; Kishimoto M; Morio A; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Neurosci Lett; 2006 May; 400(1-2):158-62. PubMed ID: 16529859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.
    Nishiyama T; Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Inada T; Furukawa T; Ozaki N
    Pharmacogenomics J; 2005; 5(2):89-95. PubMed ID: 15772696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
    Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.